On the morning of September 10, 2024, the groundbreaking ceremony for Leaf Biotechnology’s 10,000-ton FDCA production line was held in the Eastern Park of Tongling Economic & Technological Development Zone, Anhui Province. Leading officials from CPC Tongling Municipal Committee, Tongling Municipal People’s Government and University of Science and Technology of China (USTC), together with corporate shareholders and partners attended the event and laid the foundation for the project.
The project will construct the world’s first 10,000-ton production line for FDCA, a key bio-based monomer. With an estimated total investment of RMB 1 billion, Phase I under construction costs RMB 400 million and covers a land area of 85 mu, scheduled for formal commissioning by the end of 2025. Upon full operation, the plant will deliver an annual FDCA output of 15,000 tons with an expected annual output value exceeding RMB 1 billion. Adopting full continuous-process technology, the production uses low-cost glucose and non-grain biomass enzymatic hydrolysate as feedstock. Relying on self-developed catalytic systems, continuous-flow reactors and fixed-bed oxidation units, the process realizes high-efficiency isomerization-dehydration and ambient-air oxidation under mild conditions. The proprietary catalytic and synthetic technologies enable large-scale low-cost FDCA manufacturing and accelerate widespread downstream adoption of furan-based bio-based new materials.
This article is sourced from Leaf Biotechnology; click the link below to view the original post.
